Volume 25, No 1, Jan 2015

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 25 Issue 1, January 2015: 148-148

CORRIGENDUM

Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells

Makoto Sahara1,2,3,4, Emil M Hansson1,2, Oliver Wernet5, Kathy O Lui1,2,3, Daniela Später1,2,3 and Kenneth R Chien1,2,4

1Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA
2Harvard Stem Cell Institute, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA
3Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
4Department of Medicine-Cardiology/Cell and Molecular Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden
5Department of Anesthesiology and Intensive Care Medicine, Charité-University Medicine Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany Correspondence:

The protocol in the current study was developed using BIO as the GSK-3β inhibitor and works with other inhibitors as well. The strength and specificity of inhibition can increase efficiency of Phase I. The authors apologize for the mistyped GSK-3β inhibitor that was used in these studies. We would like to correct this immediately, which is noted only in three sentences in separate places in the paper. This does not impact on any of the results or the protocol mentioned in the paper and the results stand as is.

10.1038/cr.2015.2

FULL TEXT | PDF

Browse 1640